Mixed Herbal Extract Composition for Body Fat Reduction

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Current obesity treatments, including drugs and health functional foods, lack consistent efficacy and are associated with significant side effects, while there is a need for natural products with proven obesity-improving effects.

Innovation Solution

A food and pharmaceutical composition utilizing a mixed extract of Taraxacum platycarpum and Lonicerae japonica as active ingredients, which reduces body weight and fat, suppresses fat synthesis, and regulates fat metabolism.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Quantity of substance

If psychotropic antiobestic drugs are used for obesity treatment, then appetite suppression and weight reduction effects are achieved, but serious side effects such as increased blood pressure, increased respiration, impaired consciousness, and hypothyroid occur

Engineering Contradiction:
Improvebody fatVSAvoidside effects
Core Design Contradiction:
Quantity of substanceVSObject-affected harmful factors

Solution Approach 1:

The patent replaces long-term psychotropic drugs with natural plant extracts that can be used continuously without accumulating harmful effects. The extracts from Taraxacum platycarpum and Lonicerae japonica provide sustained fat metabolism support without the tolerance buildup and severe side effects associated with conventional antiobestic drugs.

Inventive Principle:
Principle #27Cheap short-living objects (Disposable)

Solution Approach 2:

The patent introduces natural plant extracts as intermediary substances that mediate fat metabolism through gentle physiological pathways. These extracts contain bioactive compounds that indirectly support weight management by regulating lipid metabolism enzymes and hormone levels, avoiding the direct central nervous system suppression mechanism of psychotropic drugs.

Inventive Principle:
Principle #24Intermediary (Mediator)

2Quantity of substance

If CLA (conjugated linolenic acid) is administered for body weight reduction, then fat absorption is reduced and fat accumulation is suppressed, but insulin resistance increases and fatty liver is caused

Engineering Contradiction:
Improvebody fatVSAvoidinsulin resistance and fatty liver
Core Design Contradiction:
Quantity of substanceVSObject-generated harmful factors

Solution Approach 1:

The patent changes the chemical composition parameters by using diverse plant extract compounds instead of a single fatty acid supplement. The extracts contain multiple phytochemicals including flavonoids, polyphenols, and triterpenes that work synergistically to regulate fat metabolism without the metabolic disturbances caused by high-dose CLA supplementation.

Inventive Principle:
Principle #35Parameter changes

Solution Approach 2:

The patent uses composite plant extracts combining Taraxacum platycarpum and Lonicerae japonica, which contain multiple bioactive compounds working together. This composite approach provides balanced fat metabolism regulation that avoids the harmful effects of single-substance interventions like CLA, by simultaneously supporting lipid breakdown and preventing fat deposition through multiple mechanisms.

Inventive Principle:
Principle #40Composite materials

3Object-affected harmful factors

If natural product-based health functional foods are used for obesity treatment, then side effects are reduced and accessibility is improved, but consistent efficacy is not demonstrated

Engineering Contradiction:
Improveside effectsVSAvoidefficacy consistency
Core Design Contradiction:
Object-affected harmful factorsVSReliability

Solution Approach 1:

The patent merges two complementary plant extracts: Taraxacum platycarpum (dandelion) which has liver-protective and lipid-metabolizing properties, and Lonicerae japonica (honeysuckle) which has anti-inflammatory and metabolic-regulating effects. This combination creates a synergistic formulation that addresses multiple aspects of obesity pathophysiology simultaneously, providing more consistent and reliable efficacy than single-herb preparations.

Inventive Principle:
Principle #5Merging (Combining)

Data Source

PatentUS20250339484A1Composition for body fat reduction containing extracts of taraxacum platycarpum and lonicerae japonica as active ingredients
Publication Date: 2025.11.06 BOINBIO CONVERGENCE CO LTD
  • US20250339484A1 patent drawing
  • US20250339484A1 patent drawing
  • US20250339484A1 patent drawing

AI summary

The present invention relates to a composition for body fat reduction containing extracts of Taraxacum platycarpum and Lonicerae japonica as active ingredients. It has been confirmed that a mixed extract of Taraxacum platycarpum and Lonicerae japonica according to the present invention reduces body weight and body fat when administered to mice with obesity induced by a high-fat diet. Also, it has been confirmed that the mixed extract reduces the size of fat tissue, reduces fat vacuoles (pore) in liver tissue, reduces total cholesterol, triglycerides, and LDL-cholesterol in the blood, and increases HDL-cholesterol. Furthermore, it has been confirmed that the mixed extract suppresses the expression of PPAR-γ which is related to fat synthesis. In addition, it has been confirmed that the mixed extract has a synergistic effect on the regulation of intracellular fat accumulation and fat metabolism factors in cells in which fat accumulation is induced.